<DOC>
	<DOCNO>NCT01417442</DOCNO>
	<brief_summary>The purpose study determine whether BRAF V600E mutation patient papillary thyroid cancer association poor prognosis .</brief_summary>
	<brief_title>BRAF V600E Mutations In Papillary Thyroid Carcinoma</brief_title>
	<detailed_description>Papillary thyroid carcinoma ( PTC ) common type thyroid malignancy BRAF V600E mutation common genetic alteration identify PTC , range 25 80 % , average rate 45 % . Various study demonstrate relationship BRAF V600E mutation aggressive characteristic cancer , include bad patient prognosis . But , study Turkey regard topic . So investigators examine BRAF V600E mutation patient PTC try ass role mutation prognosis management patient .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Thyroid Diseases</mesh_term>
	<mesh_term>Thyroid Neoplasms</mesh_term>
	<criteria>Patients papillary thyroid cancer Patients want part study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>papillary thyroid carcinoma</keyword>
	<keyword>BRAF V600E</keyword>
	<keyword>poor prognosis</keyword>
	<keyword>aggressive</keyword>
</DOC>